Below are the list of articles published in Pharmaceutical Regulatory Affairs: Open Access that have been cited by eminent researchers all around the world.
The Disparity of Motivational Drivers in International Health Care Systems |
|
Cancer Tragedy in this Century and the Role of OMICS Group Open Access Journals in Overcoming this Matter |
|
Regulatory Inspection of Clinical Trials |
|
Outpatient (Ambulatory) Pharmacy; an Innovation in Dispensing System to Optimize Performance and Meet Standards |
|
Responsibility of Regulatory Affairs in Pharmaceutical Industry |
|
Attainment of Sterility and Satisfactory Material Functional Compatibility to Devices in the Clean Room |
|
Antibiotic Abuse in Developing Countries |
|
How to Meet Legitimate Expectations of Patients when Authorized Medicinal Products are not Available |
|
Ultraviolet A Radiation, Reactive Oxygen Species and NF-kappa B |
|
Journal of Pharmaceutical Regulatory Affairs: Filling the Gap between Science and Usability |
|
Does the Requirement of Readability Testing Improve Package Leaflets? Evaluation of the 100 Most Frequently Prescribed Drugs in Germany Marketed before 2005 and First Time in 2007 or After |
|
De-convoluting the European Commission Cosmos |
|
Cutting Edge of Pharmaceutical Nanotechnology |
|
Management of Diabetes in Africa: The Role of Traditional Medicines |
|
A Country Perspective in Exploring the links between Hospital Pharmacies and Pharmaceutical Industry: A Case Study Application |
|
Historical Overview of Pharmaceutical Industry and Drug Regulatory Affairs |
|
Death after Quadrivalent Human Papillomavirus (HPV) Vaccination:Causal or Coincidental? |
|
Negative Effects of Addiction |
|
Science Requires Coexisting of Opposite Opinions:“One Country, Two Systems” |
|
Mucoadhesive Micro and Nanoparticles for Oral Controlled Drug Delivery System for Prolongation of Gastric Residence and Its Application |
|
Novel Drug Therapies and Diagnostics for Personalized Medicine and Nanomedicine in Genome Science, Nanoscience, and Molecular Engineering |
|
Multicentre Clinical Trial Monitoring |
|
Pharmaceutical Regulation: Crossroad of Opportunity as the Distinction between Food and Drugs Blurs |
|
Hold Time Stability Studies in Pharmaceutical Industry: Review |
|
Why the Study of Cancer Needs a Systemic Approach? |
|
Drug Repositioning: Discovering New Virtues in The Past |
|
Micellar Solubilization in the Formulation Development of Poorly Soluble Naproxen |
|
Non-Equivalence of Antibiotic Generic Drugs and Risk for Intensive Care Patients |
|
A Planning Model of Pharmaceutical Needs for Mass Gatherings at Public Special Events |
|
Academia-Industry Partnerships as Incubators for Economic Development |
|
Availability and Dispensing Practices for Antimalarials and Antimicrobials in Western Kenyan Pharmacies |
|
Clinical Trials Regulations in India |
|
FDA Regulation of Medical Devices and Medical Device Reporting |
|
Internal Facilitation Committees Improving Protocol Design Feasibility |
|
Group A2 Analogs of Innovator Teicoplanin: Variability of their Ratio during Treatment Time Course in Human Blood; Consequences for the Generics |
|
Cost-Effectiveness Analysis of Neoadjuvant Chemotherapy with Intensive Dose of Epirubicin and Different Cycles in Patients with Locally Advanced Breast Cancer: 4 Fe100c Vs. 6 Fe100 C |
|
Amide-based Disulfide Building Blocks for the Enlargement of the Solid Phase Peptide Synthesis for Molecular Diagnostics and Imaging |
|
Are the Quality and Safety of Magistral Preparations Guaranteed Enough? |
|
Is SteradR from J&J is Truly Plasma Gas Sterilizer? |
|
Regulations on Adaptive Design Clinical Trials |
|
Regulatory Practice in Pharmaceutical Industry |
|
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport |
|
The Three-Level Approach: A Framework for Ensuring Medicines Quality in Limited-Resource Countries |
|
The Use of Medicinal Plants in Human Healthcare: A Scoop on Safety |
|
Treatments for Type 2 Diabetes; a Focus on DPP4 Inhibitors |
|
AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease |
|
Capacity Utilization in Pharmaceutical Industry in Nigeria |
|
How to Conquer the Inconsistency of D Value Determined by Survivor Curve Method and Fraction Negative Method |
|
Pharma Regulations for Generic Drug Products in India and US: Case Studies and Future Prospectives |
|
Regulation of the Risk of Exposure to Antibiotics in Milk |
|
Role of Essential Drug List in Effective Management of Essential Anti- Malarial Drugs in Healthcare System of Pakistan Challenges in Policy Development to Practice |
|
The Vision of Better Medicines for Children and the Role of Regulatory Authorities |
|
BSE-Prion |
|
Conotoxins and their Regulatory Considerations |
|
Drug Regulatory Affairs in Quality Management |
|
On the Multiscale Nature of Human Prostate Cancer |
|
Qualified and Validated Analytical Procedures for Pharmaceutical Products Majoring from Biological Origins |
|
Recent Developments in Cancer Treatment: A Review |
|
Serum or Saliva Extraction of Toxic Compounds from Methyl Methacrylate Dental Materials and HPLC Analysis Combined with SPE |
|
Electrochemical Detection versus Ultraviolet Detection |
|
Approved Deviation of D Value and that of Population by ISO is Scientifically Correct? |
|
Comparison of Radiation Resistant among Polysulfones Prepared from Several Aromatic Diol and 4,4’-Dichlorodiphenyl Sulfone |
|
Falsified Explanation, Mechanism and Data from SterradR, Plasma ClusterR and Nano-ER |
|
What is the Major Factors to Kill Bacterial Spores by Nitrogen Gas Plasma Sterilization |
|
Role of Metastable and Spore Hydration to Sterilize Spores by Nitrogen Gas Plasma Exposure and DPA Analysis by HPLC and UV |
|
Screening of Compounds from an FDA-Approved Drug Library for the Ability to Inhibit Aspartic Protease Secretion from the Pathogenic Yeast Candida albicans |
|
New Therapeutic Approaches in Treating Cancer |
|
Impact of Pharmacovigilance in Healthcare System: Regulatory Perspective |
|
Immobilized Enzyme Column Combined with HPLC and Column Switching Method for the Analysis of Complicated Matrix Such As Body Fluids |
|
Effect of Humidity on Sterilization Using Photocatalyst |
|
Comparison on Safety Concern Among Gamma-Ray, Autoclave and Ethylene Oxide Gas Sterilizations of Thermosetting Polyurethane |
|
Bio-Relevant and Bioequivalence Studies: An Overview |
|
Application of Longitudinal Analysis for Regulatory Science |
|
Inactivation of Endotoxin and Lipid A by Nitrogen Gas Plasma Exposure Running title: Inactivation Endotoxin and lipid A |
|
The Brain Drain of Qualified Clinical Pharmacy Professionals in Pakistan’s Pharmacy Education: A Retrospective Study |
|
Simultaneous Achievement of Sterility Assurance Level (SAL) of 10-6 and Material and Functional Compatibility in Gas Plasma Sterilization Running Title: Simultaneous SAL and Compatibility |
|
An Initiative to Ensure Profession Preparedness |
|
Smoking Influences the Yield of Dendritic Cells for Cancer Immunotherapy |
|
Is It Right Time to Construct New Radiopharmaceutical Development Strategies? |
|
Sri Lankan Perspectives on Pharmacist Administered Vaccinations |
|
The Gas Plasma Sterilization |
|
Efficacy and Safety of Olive in the Management of Hyperglycemia |
|
Pharmaceutical Impurities and Degradation Products: An Overview |
|
The Pharmaceutical Industry: A Call for Change |
|
An Overview of Pharmaceutical Impurities and Degradation Products |
|
Increased Sterility by Fenton Reaction and Increased OH Radicals upon UV Irradiation-Comparison of Sterility between Fenton Reaction and UV Irradiation to Hydrogen Peroxide |
|
Impact of API (Active Pharmaceutical Ingredient) Source Selection on Generic Drug Products |
|
Sterilization Validation of Gas Plasma Exposure Based on ISO Documents (Mainly ISO TC 198 And 194 Documents) |
|
Current Mistaken Interpretation of Microbiological Data on Gas Plasma Sterilization |
|
Research into Materials Used in Abdominal Wall Repair |
|
Current Regulatory Scenario for Conducting Clinical Trials in India |
|
Human Platelet Concentrates and Derivatives Preparation Issues Pretransfusion |
|
Regulation of Herbal (Traditional) Medicinal Products in the European Union |
|
Future Prospective of Cancer Vaccination Technology in Japan |
|
Validation Study of Nitrogen Gas Plasma Exposure Based on ISO Documents (Mainly ISO TC 198 and 194 Documents) |
|
Gas Plasma Exposure to Bacterial Spore, Endotoxin and Prion |
|
Performance of Qualification of Ethylene Oxide Gas Sterilization Process |
|
Regulations in Development of Biosimilars |
|
Solid Lipid Nanoparticle: An Overview |
|
Health Hazards in the Pharmaceutical Industry |
|
Theoretical Studies of Substituted N-(1H-Benzimidazol-2ylmethyl)-5,6,7,8-Tetrahydro-8-Quinolinamines as CXCR4 Antagonists: QSAR Approach |
|
The Proteins of Type IV Secretion System as Promising Candidates for Helicobacter pylori Vaccine |
|
Digitization of Clinical Trials in India: A New Step by CDSCO towards Ensuring the Data Credibility and Patient Safety |
|
Regulatory Need: Harmonized PIC/S GMP, Its Overview and Comparison with WHO GMP |
|
The Study of Inhibitory Effects of Satureja khuzestanica Essence against Exos Gene of MDR Pseudomonas aeruginosa by RT-PCR Technique |
|
On Statistical Principles for Clinical Trials in Pharmaceutical Development – A Review of China FDA Draft Guidance |
|
Considering an Important Point When Handling Gas Plasma Sterilization |
|
The Retail Pharmacy Market in the Brazilian Federal District |
|
Malaysian Cosmetic Market: Current and Future Prospects |
|
Case Report Form (CRF) Design Made Easy: An Evaluation of Clinical Data Acquisition Standards Harmonization (CDASH) in Use |
|
Compliance to Private Healthcare Facilities and Services Act and Regulations amongst Primary Care Private Clinics in a State in Malaysia |
|
Drug Review Differences across the United States and the European Union |
|
VDAC as a Potential Target in Huntingtons Disease Therapy: The State of the Art |
|
Assessment of Dependence Liability of New Molecular Entities under the Current FDA Draft Guidance Document: “Seeking Best Practices” |
|
A Case Study on National List of Essential Medicines (NLEM) in India and WHO EML 2015-Overview |
|
Different Approaches and Timeframes in Anti-Counterfeiting Medicinal Products: Europe vs. United States |
|
Values and Disadvantages of Outsourcing the Regulatory Affairs Tasks in the Pharmaceutical Industry in EU Countries |
|
Collaboration and Socialization of Health Care Professionals to Improve the Clinical and Pharmaceutical Patients Care |
|
Emergence in the Lipid-Based Nanostructured Systems for Optimizing Oral Delivery of Drugs |
|
Regulatory Approach to Ensure Quality of Products - An Indian Perspective of Missing Linkage |
|
Brazilian Regulation in Pharmacovigilance: A Review |
|
Biosimilars: an Emerging Market Opportunities in India |
|
Pharmaceutical Good Manufacturing Practice Regulatory Affairs in Sudan: Continuous Debate between Regulatory Authority and Manufacturers |
|
The Development of Medical Devices in Foreign Markets |
|
Harmonized Guideline on Limit and Testing of Elemental Impurities in Pharmaceutical Substances: A Review |
|
Simultaneous RP-HPLC Method Development and Validation of Atorvastatin, Ezetimibe and Fenofibrate |
|
Organophosphate (OP) Poisoning Case Report by the Ingestion of a Potential Lethal Dose; its Management and Appropriate Protocol |
|
Development of Innovative Medicines for European Patients and Impact of Brexit |
|
Health and Beauty Cosmeceuticals Industry and Market Expansion in Saudi Arabia |
|
Second Medical use Patents for Medicinal Products in the EU: When is Being Skinny not enough? |
|
Canada's Natural Health Products: A Regulatory Overview |
|
E-pharmacies Regulation in India: Bringing New Dimensions to Pharma Sector |
|
Ensure Quality Assurance for Companies and Institutions |
|
Nationwide Registries Associated with Cardiovascular Medical Devices in Japan |
|
Medical Devices Regulation in United States of America, European Union and India: A Comparative Study |
|
Policy Change to Adequately Address Monitoring Conduct in a Risk-Based Environment |
|
Conducting Preclinical Abuse Liability Screening in Only One Sex: Making a Case for “Reasonable Exclusion” |
|
Product Life Cycle Management in Regulated Market of Europe |
|
Cataract Forestalling by Antioxidant Activity of Vitamin C; Amelioration of Cataract by Nutritional Intervention |
|
Evaluation of Insulin Delivery Strategies for Bronson Health Group |
|
Effective Processes for Quality Assurance |
|
Ever-greening in Pharmaceuticals: Strategies, Consequences and Provisions for Prevention in USA, EU, India and Other Countries |
|
UPLC Analytical Method Development and Validation for the Simultaneous Estimation of Paracetamol and Caffeine Capsules Dosages Form |
|
Pharmacovigilance in the Russian Federation: Construction, Development and Reforms of PV System |
|
Stress Testing of Quetiapine Fumarate by a Chemometric Assisted Multi-Component Ion-Interaction System |
|
Botanical Regulation: Comparison of the United States and Canada |
|
Regulatory Framework of Orphan Medicines in Albania |
|
Post Marketing Surveillance of Anti-malarial Medicines in Tanzania |
|
The Democratization of Dental Implants for General Dentistry |
|
Post Marketing Surveillance Requirements of Drug Eluting Stents in India and European Union |
|
The Implementation of an Expert Pharmacotherapeutic Information System in Bulgaria–Perspectives and Challenges |
|
Outsourcing Clinical Trials Outside of the US |
|
Rx: Observe, Do not Treat When is it Appropriate not to Treat? |
|
A Plant is NOT Medicine: Plant vs. Constituent Element |
|
Independent Data Monitoring Committees and Heterogeneity in MRCTs: Issues and Recommendations |
|
An Overview of Drug Master Files |
|
A Budding Cannabis Cottage-Industry has set the stage for an Impending Public Health Crisis |
|
Line of Sight: Improving Supply Chain Visibility |
|
Regulatory Challenges of Brain Delivered Therapies: A Combination Product Perspective |
|
Marijuana Toxicity: Heavy Metal Exposure Through State-Sponsored Access to âÃâ¬ÃÅla Fee VerteâÃâ¬Ã |
|
What are the Implications of the Use of Modafinil as a Study Drug? |
|
Strategies and Steps for the Accomplishment of Bioequivalence Regulations in Chile |
|
GLPs, Human Error, and Deviations: When Are Quality and Integrity Compromised? |
|
Informed Consent Elements for Pharmacogenetic Research: An Overview |
|
Benefits of Conducting Clinical Trials in Developing Countries like India |
|
Patient Compliance: An Untold Story or a Fairy Tale? |
|
“New Drugs and Clinical Trials Rules-2018” (GSR-104 E) by CDSCO: It’s Impact on BA/BE Studies in India |
|
Formulation and In-vitro Evaluation of Sumatriptan Succinate Bilayer Tablets |
|
Regulatory Requirements and Drug Approval Process in India, Europe and US |
|
Pharmaceutical Market of Uzbekistan Investment Klondike without Side Effects |
|
Generic Drugs, A Need to the Public: USA and India- Government Plans to Reduce the Price of ANDA and List of Generic Drugs Approved in Year 2018 |
|
Readability of Package Leaflets – Update on Possible Improvements Using an Electronic Version Additionally |
|
Conceptual Drug Discovery and Societal Status may not be Sufficient to Combat Multidrug-Resistant Infections |
|
Drug Discovery and Development: An Overview from the Regulatory Prospective |
|
Role of Nutraceuticals as an Alternative Pharmaceutical for Medicinal & Health Benefits |
|
Overview of Current Regulations Governing Medical Devices |
|
Physico-chemical and Preliminary Phytochemical Study of Seeds of Datisca cannabina Linn (Datiscaceae) from Himalaya Region in Pakistan |
|
Product Labeling of Drugs Commonly Administered to Children and Adults with Obesity |
|
Schedule I Control Status Does Not Impede Legitimate Nonclinical Research in the United States |
|
Formulation Development, Preparation and Evaluation of Taste Masking Orodispersible Tablet of Tiemonium Methylsulfate by using HPMC as Taste Masking Agent |
|
Analytical Method Development and Validation of Preservative Benzalkonium Chloride in Ciprofloxacin Eye Drops by HPLC |
|
The Development of Botanical Drugs â A Review |
|
Walking in the Field of Pharmaceutical Regulatory in Albania |
|
Detecting Falsified Viagra Using Miniaturized Consumer Near-Infrared Spectroscopy |
|
Editorial Note for Journal of Pharmaceutical Regulatory Affairs: Open Access |
|
Detecting Falsified Viagra Using Miniaturized Consumer Near-Infrared |
|
Analytical Method Development and Validation of Preservative Benzalkonium Chloride in Ciprofloxacin Eye Drops |
|
Schedule I Control Status Does Not Impede Legitimate Nonclinical Research |
|
Product Labeling of Drugs Commonly Administered to Children and Adults |
|
Physico-chemical and Preliminary Phytochemical Study of Seeds of Datisca cannabina Linn (Datiscaceae) from Himalaya Region |
|